|
Search
Collections
Benchmarks
Upload document
Palifermin
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Busulfan, melphalan, and carfilzomib (BuMelCar) conditioning for autologous stem cell transplant (ASCT) in multiple myeloma: Phase I/II data.
Org:
Loyola University Medical Center,
Maywood, IL,